Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001654954-25-005950
Filing Date
2025-05-20
Accepted
2025-05-20 18:54:40
Documents
1
Period of Report
2025-05-16

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT section16.html 4  
1 PRIMARY DOCUMENT section16.xml 4 12601
  Complete submission text file 0001654954-25-005950.txt   14395
Mailing Address 101 GLEN LENNOX DRIVE SUITE 300 CHAPEL HILL NC 27517
Business Address 101 GLEN LENNOX DRIVE SUITE 300 CHAPEL HILL NC 27517 919-855-2100
TENAX THERAPEUTICS, INC. (Issuer) CIK: 0000034956 (see all company filings)

EIN.: 262593535 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O TENAX THERAPEUTICS, INC. ONE COPLEY PARKWAY, SUITE 490 MORRISVILLE NC 27560
Business Address
Rich Stuart (Reporting) CIK: 0001841785 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-34600 | Film No.: 25970474